Literature DB >> 20071071

Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis.

Ming Liu1, Minggui Yuan, Minxian Luo, Xianzhang Bu, Hai-Bin Luo, Xiaopeng Hu.   

Abstract

Glyoxalase I (GLOI) is a key metalloenzyme in glycolytic pathway by detoxifying reactive alpha-ketoaldehydes such as methylglyoxal. Recent studies demonstrate that the nature product curcumin is an efficient inhibitor of GLOI, but its binding mechanism towards GLOI is still unclear. In the present study, molecular docking and molecular dynamics (MD) simulations were performed to better understand the inhibitory mechanism of curcumin towards GLOI. The enol form of curcumin coordinates with the catalytic zinc ion of GLOI and forms a strong hydrogen bond with Glu 172, whereas its keto tautomer displays unfavorable electrostatic interactions with Glu 172 and Glu 99. The calculated binding free energies suggest that GLOI prefers the primary enol form (DeltaG=-30.38kcal/mol) to the keto tautomer (DeltaG=-24.16kcal/mol). The present work also reveals that bisdemethoxycurcumin binds to GLOI in a similar manner as curcumin and exhibits a slightly less negative predicted binding free energy, which is further validated by our comparative kinetics analysis (Ki=18.2 and 10.3muM for bisdemethoxycurcumin and curcumin, respectively). Results of the study can provide an insight into the development of novel and more effective GLOI inhibitors. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20071071     DOI: 10.1016/j.bpc.2009.12.007

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  17 in total

1.  Exploration of the binding of curcumin analogues to human P450 2C9 based on docking and molecular dynamics simulation.

Authors:  Rongwei Shi; Yin Wang; Xiaolei Zhu; Xiaohua Lu
Journal:  J Mol Model       Date:  2011-11-12       Impact factor: 1.810

2.  Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor.

Authors:  Hong Zhang; Qiang Huang; Jing Zhai; Yi-ning Zhao; Li-ping Zhang; Yun-yun Chen; Ren-wei Zhang; Qing Li; Xiao-peng Hu
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

3.  Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor.

Authors:  Christian Perez; Amanda M Barkley-Levenson; Benjamin L Dick; Peter F Glatt; Yadira Martinez; Dionicio Siegel; Jeremiah D Momper; Abraham A Palmer; Seth M Cohen
Journal:  J Med Chem       Date:  2019-01-31       Impact factor: 7.446

4.  Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.

Authors:  Yunierkis Pérez-Castillo; Matheus Froeyen; Miguel Angel Cabrera-Pérez; Ann Nowé
Journal:  J Comput Aided Mol Des       Date:  2011-04-23       Impact factor: 3.686

5.  Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking.

Authors:  Nizar A Al-Shar'i; Qosay A Al-Balas; Rand A Al-Waqfi; Mohammad A Hassan; Amer E Alkhalifa; Nehad M Ayoub
Journal:  J Comput Aided Mol Des       Date:  2019-10-19       Impact factor: 3.686

Review 6.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

7.  The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.

Authors:  Yong-Xian Shao; Peng Zhao; Zhe Li; Ming Liu; Peiqing Liu; Min Huang; Hai-Bin Luo
Journal:  Eur Biophys J       Date:  2012-01-08       Impact factor: 1.733

Review 8.  Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses.

Authors:  Paul Andrei Negru; Denisa Claudia Miculas; Tapan Behl; Alexa Florina Bungau; Ruxandra-Cristina Marin; Simona Gabriela Bungau
Journal:  Biomed Pharmacother       Date:  2022-07-18       Impact factor: 7.419

9.  Biophysical analysis of the putative acetyltransferase SACOL2570 from methicillin-resistant Staphylococcus aureus.

Authors:  Hai-Bin Luo; Aleksandra A Knapik; Janusz J Petkowski; Matthew Demas; Igor A Shumilin; Heping Zheng; Maksymilian Chruszcz; Wladek Minor
Journal:  J Struct Funct Genomics       Date:  2013-08-21

10.  Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities.

Authors:  Parisa Jahangoshaei; Leila Hassani; Fakhrossadat Mohammadi; Akram Hamidi; Khosro Mohammadi
Journal:  J Biol Inorg Chem       Date:  2015-09-14       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.